Agilent Technologies, Inc. A
172.79
(0.05)
(0.03%)
as of 25 Sep
- Market cap
- $49.0B
- P/E
- 33.9×
Follow A
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Agilent Technologies, Inc. (A) Total debt
Agilent Technologies, Inc.'s total debt at the end of fiscal 2025 was $3.1B, down 8.82% from $3.3B in fiscal 2024. At the end of the quarter to 31 July 2026 it was $3.6B. Over the past ten years it has ranged from $1.7B (fiscal 2015) to $3.3B (fiscal 2024); the current reading is higher than 91% of that period. Agilent Technologies, Inc. ranks 7th of 50 Diagnostics & Research companies by total debt.
Total debt, annual
Annual
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $3.1B | (8.82%) |
| FY2024 | $3.3B | 22.30% |
| FY2023 | $2.7B | 0.07% |
| FY2022 | $2.7B | 0.15% |
| FY2021 | $2.7B | 19.48% |
| FY2020 | $2.3B | 27.53% |
| FY2019 | $1.8B | (0.44%) |
| FY2018 | $1.8B | (0.11%) |
| FY2017 | $1.8B | (5.41%) |
| FY2016 | $1.9B | 15.05% |
Quarterly
| Period | Total debt | Change |
|---|---|---|
| Jul 2026 | $3.6B | 19.47% |
| Apr 2026 | $3.1B | 0.03% |
| Jan 2026 | $3.1B | 0.00% |
| Oct 2025 | $3.1B | (8.96%) |
| 43 more quarters | Free account |
Against its own ten years
Low $1.7B
High $3.3B
Ten-year median
$2.3B
Current reading's percentile
91
Total debt against peers
| Company | Total debt |
|---|---|
| IQV IQVIA Holdings Inc. compare | $16.0B |
| DGX Quest Diagnostics Incorporated compare | $5.6B |
| WAT Waters Corporation compare | $4.9B |
| A Agilent Technologies, Inc. | $3.6B |
| MTD Mettler-Toledo International, Inc. compare | $2.1B |
| GH Guardant Health, Inc. compare | $1.5B |
| ILMN Illumina, Inc. compare | $1.5B |
| IDXX IDEXX Laboratories, Inc. compare | $449.9M |
| NTRA Natera, Inc. compare | $80.3M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on A
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement